Wolverine Trading, LLC Crispr Therapeutics Ag Call Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Call Options

24 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$51.17 - $68.18 $296,786 - $395,444	-5,800 Reduced 7.81%	68,500 $3.7 Million
Q1 2024 May 15, 2024	SELL	$60.67 - $89.12 $1.87 Million - $2.74 Million	-30,800 Reduced 29.31%	74,300 $5.06 Million
Q4 2023 Feb 14, 2024	BUY	$38.62 - $72.18 $1.4 Million - $2.62 Million	36,300 Added 52.76%	105,100 $6.58 Million
Q3 2023 Nov 15, 2023	BUY	$45.39 - $59.0 $213,333 - $277,300	4,700 Added 7.33%	68,800 $3.12 Million
Q2 2023 Aug 23, 2023	BUY	$43.47 - $67.77 $552,069 - $860,679	12,700 Added 24.71%	64,100 $3.6 Million
Q1 2023 May 15, 2023	SELL	$41.0 - $56.12 $623,200 - $853,024	-15,200 Reduced 22.82%	51,400 $2.27 Million
Q4 2022 Feb 14, 2023	SELL	$39.19 - $65.67 $39,190 - $65,670	-1,000 Reduced 1.48%	66,600 $2.71 Million
Q3 2022 Nov 14, 2022	SELL	$61.1 - $83.78 $103,870 - $142,426	-1,700 Reduced 2.45%	67,600 $4.36 Million
Q2 2022 Aug 15, 2022	SELL	$43.23 - $73.83 $207,503 - $354,384	-4,800 Reduced 6.48%	69,300 $4.37 Million
Q1 2022 May 16, 2022	SELL	$53.19 - $79.24 $664,875 - $990,499	-12,500 Reduced 14.43%	74,100 $4.75 Million
Q4 2021 Feb 14, 2022	BUY	$70.09 - $111.29 $799,026 - $1.27 Million	11,400 Added 15.16%	86,600 $6.83 Million
Q3 2021 Nov 12, 2021	SELL	$110.2 - $156.64 $1.3 Million - $1.85 Million	-11,800 Reduced 13.56%	75,200 $8.29 Million
Q2 2021 Aug 06, 2021	SELL	$100.84 - $161.89 $262,184 - $420,913	-2,600 Reduced 2.9%	87,000 $13.1 Million
Q1 2021 May 14, 2021	BUY	$110.72 - $210.04 $3.21 Million - $6.09 Million	29,000 Added 47.85%	89,600 $10.3 Million
Q4 2020 Feb 12, 2021	BUY	$79.67 - $173.23 $2.47 Million - $5.37 Million	31,000 Added 104.73%	60,600 $9.79 Million
Q3 2020 Nov 13, 2020	SELL	$78.5 - $100.64 $180,550 - $231,472	-2,300 Reduced 7.21%	29,600 $2.52 Million
Q2 2020 Aug 13, 2020	BUY	$38.5 - $76.05 $346,500 - $684,450	9,000 Added 39.3%	31,900 $2.39 Million
Q1 2020 May 11, 2020	BUY	$33.68 - $62.53 $6,736 - $12,506	200 Added 0.88%	22,900 $1.01 Million
Q4 2019 Feb 12, 2020	SELL	$36.68 - $73.13 $605,220 - $1.21 Million	-16,500 Reduced 42.09%	22,700 $1.4 Million
Q3 2019 Nov 14, 2019	SELL	$40.99 - $52.56 $557,464 - $714,816	-13,600 Reduced 25.76%	39,200 $1.66 Million
Q2 2019 Aug 20, 2019	BUY	$35.45 - $48.2 $428,945 - $583,220	12,100 Added 29.73%	52,800 $2.49 Million
Q1 2019 May 15, 2019	SELL	$28.02 - $40.87 $42,030 - $61,304	-1,500 Reduced 3.55%	40,700 $1.45 Million
Q4 2018 Feb 14, 2019	BUY	$22.73 - $42.34 $556,885 - $1.04 Million	24,500 Added 138.42%	42,200 $1.13 Million
Q3 2018 Nov 14, 2018	BUY	$44.35 - $65.71 $784,995 - $1.16 Million	17,700 New	17,700 $785,000

Others Institutions Holding CRSP

# of Institutions

490

Shares Held

58M

Call Options Held

1.1M

Put Options Held

1.9M

Capital International Investors Los Angeles, CA

7.93M
Shares

$321 Million
0.07% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

7.5M
Shares

$304 Million
3.35% of portfolio
State Street Corp Boston, MA

2.99M
Shares

$121 Million
0.01% of portfolio
Sumitomo Mitsui Trust Holdings, Inc.

2.97M
Shares

$120 Million
0.1% of portfolio
Nikko Asset Management Americas, Inc.

2.97M
Shares

$120 Million
1.61% of portfolio

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.16B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account